Returning Aggregate Results to Research Participants/Families: Updated Recommendations From the Children's Oncology Group
In 2012, the Children's Oncology Group (COG) issued 18 recommendations for returning aggregate research results to participants. This manuscript reviews the Return of Results (ROR) Committee's progress in implementing these recommendations. A multidisciplinary review assessed implementation status, identified challenges, and incorporated relevant literature to propose updates and future research directions. Fourteen recommendations were fully or partially implemented, three were deemed infeasible, and one is planned for future action. Successful implementation was supported by infrastructure, education, and ongoing quality improvement. This experience offers a practical model for other cooperative research groups aiming to return research results beyond clinical trials.
Authors
- Tina Bocking
- Chris Williams‐Hughes
- Conrad V. Fernandez (ORCID: https://orcid.org/0000-0002-0746-8306)
- Beth Fisher (ORCID: https://orcid.org/0000-0001-6678-7035)
- Wendy Pelletier (ORCID: https://orcid.org/0000-0002-8412-9308)
- Rebecca D. Pentz (ORCID: https://orcid.org/0000-0003-4338-6663)
- Blair Segers
- Kimberly A. Pyke‐Grimm (ORCID: https://orcid.org/0000-0001-6396-7460)
- Joan Darling
- Stacey Crane (ORCID: https://orcid.org/0000-0003-3092-7256)
- Kathleen S. Ruccione
- Gina Martin
- Heidi Pusztay
Institutions
- Dalhousie University (CA)
- Children's Hospital of Philadelphia (US)
- Emory University (US)
- University of Calgary (CA)
- Augusta University (US)
- Cardinal Glennon Children’s Medical Center (US)
- Children's Oncology Group (US)
- Stanford Medicine (US)
- Eion (Canada) (CA)
- The University of Texas Health Science Center at Houston (US)
- Azusa Pacific University (US)
Publication Details
- Journal
- Pediatric Blood & Cancer
- Published
- 2025-12-27
- DOI
- https://doi.org/10.1002/1545-5017.70066
- Primary Topic
- Childhood Cancer Survivors' Quality of Life
- Type
- article
- Field-Weighted Citation Impact
- 0.00